|
FY2025
12 months to Sep 26, 2025
|
FY2024
12 months to Sep 27, 2024
|
FY2023
12 months to Sep 29, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 24, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Licensing | |||||
| Products and services | |||||
| Total revenue | |||||
| Cost of revenue: | |||||
| Cost of revenue | |||||
| Licensing | |||||
| Products and services | |||||
| Total cost of revenue | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Gain on sale of assets | |||||
| Restructuring charges | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other income/(expense): | |||||
| Interest income/(expense), net | |||||
| Other income/(expense), net | |||||
| Total other income | |||||
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | |||||
| Net income including controlling interest | |||||
| Less: net (income) attributable to controlling interest | |||||
| Nonrelated Party | |||||
| Net income attributable to Dolby Laboratories, Inc. | |||||
| Net Income Per Share: | |||||
| Basic (usd per share) | |||||
| Diluted (usd per share) | |||||
| Weighted Average Number of Shares Outstanding, Diluted | |||||
| Basic (shares) | |||||
| Diluted (shares) | |||||
| Related party rent expense: | |||||
| Included in operating expenses | |||||
| Included in net income attributable to controlling interest | |||||
| Cash dividend paid per common share | |||||
Loading...